Northrop Grumman (NOC) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Northrop Grumman (NYSE: NOC) in the last few weeks: 10/14/2026 – Northrop Grumman had its price target lowered by Sanford C. Bernstein from $620.00 to $556.00. They now have a “market perform” rating on the stock. 10/9/2026 – Northrop Grumman had its price […]
Recent Analysts’ Ratings Updates for FirstEnergy (FE)
A number of firms have modified their ratings and price targets on shares of FirstEnergy (NYSE: FE) recently: 10/19/2026 – FirstEnergy had its price target lowered by JPMorgan Chase & Co. from $52.00 to $50.00. They now have a “neutral” rating on the stock. 10/13/2026 – FirstEnergy was given a new $47.00 price target by […]
Alexandria Real Estate Equities (ARE) – Analysts’ Recent Ratings Updates
Alexandria Real Estate Equities (NYSE: ARE) recently received a number of ratings updates from brokerages and research firms: 10/15/2026 – Alexandria Real Estate Equities had its “sell (d)” rating reaffirmed by Weiss Ratings. 10/12/2026 – Alexandria Real Estate Equities was given a new $41.00 price target by Royal Bank Of Canada. 10/12/2026 – Alexandria Real […]
Franklin Resources (BEN) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Franklin Resources (NYSE: BEN): 10/14/2026 – Franklin Resources had its “mixed” rating reaffirmed by Barclays PLC. 10/14/2026 – Franklin Resources had its price target lowered by Barclays PLC from $36.00 to $34.00. They now have an “equal weight” rating on the stock. […]
Analysts’ Recent Ratings Updates for Gevo (GEVO)
A number of firms have modified their ratings and price targets on shares of Gevo (NASDAQ: GEVO) recently: 10/9/2026 – Gevo had its “buy” rating reaffirmed by HC Wainwright. 10/2/2026 – Gevo was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”. 9/29/2026 – Gevo was upgraded by Jefferies Financial Group Inc. to “hold”. […]
Analysts’ Recent Ratings Updates for Terreno Realty (TRNO)
Terreno Realty (NYSE: TRNO) recently received a number of ratings updates from brokerages and research firms: 10/12/2026 – Terreno Realty had its price target lowered by Piper Sandler from $91.00 to $85.00. They now have an “overweight” rating on the stock. 10/12/2026 – Terreno Realty was upgraded by BMO Capital Markets from “market perform” to […]
Research Analysts’ Recent Ratings Updates for GE Vernova (GEV)
GE Vernova (NYSE: GEV) has recently received a number of price target changes and ratings updates: 10/14/2026 – GE Vernova had its price target lowered by Susquehanna from $1,300.00 to $1,270.00. They now have a “positive” rating on the stock. 10/13/2026 – GE Vernova had its “buy” rating reaffirmed by Guggenheim. They now have a […]
Analysts’ Recent Ratings Updates for Citigroup (C)
Several brokerages have updated their recommendations and price targets on shares of Citigroup (NYSE: C) in the last few weeks: 10/14/2026 – Citigroup was given a new $148.00 price target by UBS Group AG. 10/14/2026 – Citigroup had its price target lowered by TD Cowen from $150.00 to $148.00. They now have a “buy” rating […]
Recent Analysts’ Ratings Updates for FirstCash (FCFS)
A number of research firms have changed their ratings and price targets for FirstCash (NASDAQ: FCFS): 10/15/2026 – FirstCash had its price target raised by Canaccord Genuity Group Inc. from $252.00 to $265.00. They now have a “buy” rating on the stock. 10/10/2026 – FirstCash was downgraded by Wall Street Zen from “buy” to “hold”. […]
Analysts’ Recent Ratings Updates for Plains All American Pipeline (PAA)
Plains All American Pipeline (NASDAQ: PAA) recently received a number of ratings updates from brokerages and research firms: 10/9/2026 – Plains All American Pipeline had its price target raised by UBS Group AG from $30.00 to $31.00. They now have a “buy” rating on the stock. 10/9/2026 – Plains All American Pipeline is now covered […]
Recent Analysts’ Ratings Updates for Generac (GNRC)
Generac (NYSE: GNRC) has recently received a number of price target changes and ratings updates: 10/8/2026 – Generac is now covered by Piper Sandler. They set an “overweight” rating and a $303.00 price target on the stock. 10/8/2026 – Generac was upgraded by KeyCorp from “sector weight” to “overweight”. They now have a $280.00 price […]
H. B. Fuller (FUL) – Analysts’ Recent Ratings Updates
H. B. Fuller (NYSE: FUL) recently received a number of ratings updates from brokerages and research firms: 9/29/2026 – H. B. Fuller had its price target lowered by Deutsche Bank Aktiengesellschaft from $72.00 to $62.00. They now have a “buy” rating on the stock. 9/28/2026 – H. B. Fuller had its price target lowered by […]
Recent Analysts’ Ratings Updates for Morgan Stanley (MS)
Morgan Stanley (NYSE: MS) has recently received a number of price target changes and ratings updates: 10/8/2026 – Morgan Stanley is now covered by TD Cowen. They set a “hold” rating and a $210.00 price target on the stock. 10/8/2026 – Morgan Stanley was downgraded by Erste Group Bank AG from “buy” to “hold”. 10/6/2026 […]
Analysts’ Recent Ratings Updates for Hub Group (HUBG)
Several analysts have recently updated their ratings and price targets for Hub Group (NASDAQ: HUBG): 10/12/2026 – Hub Group was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $29.00 price target on the stock. 10/7/2026 – Hub Group was downgraded by Zacks Research from “hold” to “strong sell”. 10/6/2026 – […]
Research Analysts’ Recent Ratings Updates for Foghorn Therapeutics (FHTX)
Foghorn Therapeutics (NASDAQ: FHTX) has recently received a number of price target changes and ratings updates: 10/2/2026 – Foghorn Therapeutics had its price target lowered by Guggenheim from $12.00 to $5.00. They now have a “buy” rating on the stock. 10/2/2026 – Foghorn Therapeutics was downgraded by Wedbush from “outperform” to “neutral”. They now have […]
Recent Research Analysts’ Ratings Updates for Vaxcyte (PCVX)
Vaxcyte (NASDAQ: PCVX) has recently received a number of price target changes and ratings updates: 10/5/2026 – Vaxcyte had its price target raised by Guggenheim from $116.00 to $125.00. They now have a “buy” rating on the stock. 10/5/2026 – Vaxcyte had its “buy” rating reaffirmed by BTIG Research. They now have a $89.00 price […]
last updated on 20 Oct 19:57